Sleep Duration in Mouse Models of Neurodevelopmental Disorders.

Brain Sci

Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health, Section on Neuroadaptation and Protein Metabolism, Bethesda, MD 20814, USA.

Published: December 2020

Sleep abnormalities are common in patients with neurodevelopmental disorders, and it is thought that deficits in sleep may contribute to the unfolding of symptoms in these disorders. Appreciating sleep abnormalities in neurodevelopmental disorders could be important for designing a treatment for these disorders. We studied sleep duration in three mouse models by means of home-cage monitoring: (tuberous sclerosis complex), oxytocin receptor () knockout (KO) (autism spectrum disorders), and KO (Phelan-McDermid syndrome). We studied both male and female mice, and data were analyzed to examine effects of both genotype and sex. In general, we found that female mice slept less than males regardless of genotype or phase. We did not find any differences in sleep duration in either or KO mice, compared to controls. In KO mice, we found a statistically significant genotype x phase interaction ( = 0.002) with a trend that KO mice regardless of sex slept more than control mice in the active phase. Our results have implications for the management of patients with Phelan-McDermid syndrome.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824512PMC
http://dx.doi.org/10.3390/brainsci11010031DOI Listing

Publication Analysis

Top Keywords

sleep duration
12
neurodevelopmental disorders
12
mouse models
8
sleep abnormalities
8
phelan-mcdermid syndrome
8
female mice
8
genotype phase
8
sleep
6
disorders
6
mice
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!